Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Oncogene. 2015 Aug 24;35(18):2299–2310. doi: 10.1038/onc.2015.299

Figure 6.

Figure 6

Tpl2 expression blocks the tumorigenicities of human NF-κB1low lung cancer cells. (a) IB assays confirming the expression of exogenous HA-tagged Tpl2 in human lung cancer stable cell lines. (b) Cell growth assays showing decreased growth rate of Tpl2 human lung cancer stable cell lines. Cells were cultured 3 days before growth assays. Data shown are means ± SD (n ≥ 3; *, p < 0.05; **, p < 0.01). (c) Soft agar colony formation assays showing decreased anchorage-independent growth of Tpl2 human lung cancer stable cell lines. Data shown are means ± SD (n ≥ 3; **, p < 0.01).